Written Question·Department of Health and Social Care·UIN 107546

Prostate Cancer: Abiraterone

Tabled: 21 January 2026

Answered: 28 January 2026

Question

Sorcha Eastwood

To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential impact of Northern Ireland being the only part of the UK without routine access to abiraterone for men with non-metastatic prostate cancer on patient

Answer

Dr Zubir Ahmed

There are no current plans to hold discussions with the Northern Irish Department of Health or the Health and Social Care Board on abiraterone access in Northern Ireland. Decisions on the availability of medicines in Northern Ireland are a matter for the ...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 107546) →